Hospital and health care provider advocates this week once again urged federal lawmakers to reject a controversial GOP-backed reconciliation plan [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The head of a key U.S. House subcommittee that oversees 340B drug pricing program policy issues is leaving the chairmanship [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drugmakers recently announced additional states that will no longer be subject to their 340B contract pharmacy restrictions following [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rhode Island on Friday became the 21st state to enact 340B contract pharmacy protections as Gov. Dan McKee (D) signed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rhode Island lawmakers wrapped up their 2025 legislative session by passing contract pharmacy access bills that contain provider reporting requirements [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...] …